Watchlist Price Alert

Atossa Therapeutics Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

0.82

0.01 (1.26%)

At close: May 09, 2025, 3:59 PM

0.80

-2.38%

After-hours: May 09, 2025, 05:36 PM EDT

1.26% (1D)

Bid	0.8
Market Cap	106.31M
Revenue (ttm)	n/a
Net Income (ttm)	-25.5M
EPS (ttm)	-0.2
PE Ratio (ttm)	-4.11
Forward PE	-2.79
Analyst	Buy

Ask	0.85
Volume	455,058
Avg. Volume (20D)	616,309
Open	0.81
Previous Close	0.81
Day's Range	0.81 - 0.84
52-Week Range	0.55 - 1.74
Beta	1.02

About ATOS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ATOS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ATOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

News

1 month ago · zacks.com

All You Need to Know About Atossa Genetics (ATOS) Rating Upgrade to Buy

Atossa Genetics (ATOS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 month ago · seekingalpha.com

Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call Transcript

Atossa Therapeutics, Inc. (NASDAQ:ATOS ) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ET Company Participants Michael Parks - VP of Investor and Public Relations Steven Quay - President and...